A positive correlation of serum homocysteine with leptin in maintenance hemodialysis patients

Archives of Medical Science

Volumn 2, Issue 3, 2006, Pages 185-189

  Nasri, Hamid ^a  

^a SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Body mass index; Homocysteine; Leptin; Maintenance hemodialysis patients; Malnutrition inflammation cachexia syndrome

Indexed keywords

CALCITRIOL; CALCIUM CARBONATE; COLECALCIFEROL; FERRIC HYDROXIDE SUCROSE; FOLIC ACID; HOMOCYSTEINE; LEPTIN; LEVACECARNINE; RECOMBINANT ERYTHROPOIETIN; SEVELAMER; VITAMIN B COMPLEX;

ADULT; AGED; ANEMIA; ARTICLE; BODY MASS; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; KIDNEY DISEASE; MALE; NUTRITIONAL STATUS;

EID: 33750604579     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Moudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds). The Metabolic Basis of Inherited Disease, 6th ed. McGraw-Hill, New York, 1989; 693-774.
2. Nasri H, Baradaran A. Association of serum homocysteine with anemia in maintenance hemodialysis patients. Pakistan Journal of Nutrition 2005; 4: 414-7.
3. Eikelboom JW, Lonn E, Genest J Jr, Hankey G, Yusuf S. Homocyst(e)ine and cardiovascular disease: a critical review of the epidemiologic evidence. Ann Intern Med 1999; 131: 363-75.
4. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32 (5 Suppl 3): S112-9.
5. Sirrs S, Duncan L, Djurdjev O, Nussbaumer G, Ganz G, et al. Homocyst(e)ine and vascular access complications in haemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 1999; 14: 738-43.
6. Suliman ME, Qureshi AR, Barany P, Stenvinkel P, Filho JC, et al. Hyperhomocysteinemia, nutritional status, and cardiovascular disease in hemodialysis patients. Kidney Int 2000; 57: 1727-35.
7. Wrone EM, Zehnder JL, Hornberger JM, McCann LM, Coplon NS, et al. An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease. Kidney Int 2001; 60: 1106-13.
8. Suliman ME, Stenvinkel P, Qureshi AR, Barany P, Heimburger O, et al. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am J Kidney Dis 2004; 44: 455-65.
9. Mallamaci F, Zoccali C, Tripepi G, Fermo I, Benedetto FA, et al. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients. Kidney Int 2002; 61: 609-14.
10. Kalantar-Zadeh K, Block G, Humphreys MH, McAllister CJ, Kopple JD. A low, rather than a high, total plasma homocysteine is an indicator of poor outcome in hemodialysis patients. J Am Soc Nephrol 2004; 15: 442-53.
11. Suliman ME, Stenvinkel P, Barany P, Heimburger O, Anderstam B, et al. Hyperhomocysteinemia and its relationship to cardiovascular disease in ESRD: influence of hypoalbuminemia, malnutrition, inflammation, and diabetes mellitus. Am J Kidney Dis 2003; 41 (3 Suppl 1): S89-95.
12. Suliman ME, Lindholm B, Barany P, Bergstrom J. Hyperhomocysteinemia in chronic renal failure patients: relation to nutritional status and cardiovascular disease. Clin Chem Lab Med 2001; 39: 734-8.
13. Kalantar-Zadeh K, Block G, Humphreys MH, Kopple JD. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 2003; 63: 793-808.
14. Fleischmann EH, Bower JD, Salahudeen AK. Risk factor paradox in hemodialysis: better nutrition as a partial explanation. ASAIO J 2001; 47: 74-81.
15. Nishizawa Y, Shoji T, Ishimura E, Inaba M, Morii H. Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia? Am J Kidney Dis 2001; 38 (4 Suppl 1): S4-7.
16. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 2003; 42: 864-81.
17. Ifudu O, Uribarri J, Rajwani I, Vlacich V, Reydel K, et al. Low hematocrit may connote a malnutrition-inflammation syndrome in hemodialysis patients. Dial Transplant 2002; 31: 845-78.
18. Wolf G, Chen S, Han DC, Ziyadeh FN. Leptin and renal disease. Am J Kidney Dis 2002; 39: 1-11.
19. Baradaran A, Nasri H. Correlation of Serum Leptin with Circulating Anti-Helico Bacter Pylori IgG Antibodies in End-Stage Renal Failure Patients on Regular Hemodialysis. Pakistan Journal of Nutrition 2005; 4: 389-92.
20. Pecoits-Filho R, Lindholm B, Stenvinkel P. End-stage renal disease: a state of chronic inflammation and hyperleptinemia. Eur J Clin Invest 2003; 33: 527-8.
21. Don BR, Rosales LM, Levine NW, Mitch W, Kaysen GA. Leptin is a negative acute phase protein in chronic hemodialysis patients. Kidney Int 2001; 59: 1114-20.
22. Baradaran A, Nasri H. Association of Serum C-Reactive Protein (CRP) with Some Nutritional Parameters of Maintenance Hemodialysis Patients. Pakistan Journal of Nutrition 2005; 4: 175-182.